Leupo-22.5Mg Inj Substitute
RXIpca Laboratories Ltd
₹12047.5
(₹12047.5 per unit)
RXBDR Pharmaceuticals Internationals Pvt Ltd
₹13094
(₹13094.0 per unit)
RXZydus Cadila
₹16993
(₹16993.0 per unit)
RXHetero Healthcare Ltd
₹17934
(₹17934.0 per unit)
RXSamarth Life Sciences Pvt Ltd
₹17934.5
(₹17934.5 per unit)
RXAxiommax Oncology Pvt Ltd
₹18188
(₹18188.0 per unit)
RXEris Life Sciences Ltd
₹18500
(₹18500.0 per unit)
RXBAJAJ HEALTHCARE LTD
₹18990
(₹18990.0 per unit)
RXDel Trade International Pvt Ltd
₹19131
(₹19131.0 per unit)
RXRanbaxy Laboratories Ltd
₹24892
(₹24892.0 per unit)

Patients may explore substitutes in the following scenarios:
Before you switch from Leupo-22.5Mg Inj to another medicine, here are some important points to keep in mind:
Most substitutes contain the same active ingredient - LEUPRORELIN-22.5MG, but the fillers, coating, or manufacturing quality may vary slightly.
Even if the salt is the same, your doctor can confirm if the substitute is right for your condition, dosage, and health history.
Some people may react differently to certain brands due to inactive ingredients. If you notice any side effects, inform your doctor immediately.
A lower-priced substitute doesn't mean it's less effective. Many generic medicines work just as well as branded ones.
Always match the substitute’s strength (e.g., 5mg, 10mg) and form (tablet, capsule, syrup) with what your doctor prescribed.
Leupo-22.5Mg Inj is used in the treatment of prostate cancer, breast cancer, endometriosis, and premature puberty. The detailed uses of Leupo-22.5Mg Inj are as follows:
Leupo-22.5Mg Inj contains Leuprorelin which works similarly to the natural hormone, gonadotropin-releasing hormone (GnRH), by acting on the pituitary gland and decreasing the levels of testosterone in men and oestrogen in women. Thereby, Leupo-22.5Mg Inj is used in the treatment of prostate cancer by inhibiting the growth of the tumour or causing it to shrink. Also, Leupo-22.5Mg Inj is used to treat hormone-responsive breast cancer in pre and postmenopausal women. By reducing testosterone and oestrogen levels, Leupo-22.5Mg Inj delays the onset of puberty in children.
The substitutes of Leupo-22.5Mg Inj contain the same active salt(s) - LEUPRORELIN-22.5MG. However, they may differ in price, manufacturing quality, and inactive ingredients. Speak to your doctor to find a suitable option.
Switching to a generic substitute medicine in the place of Leupo-22.5Mg Inj is often possible if it has the same salt, strength, and dosage form. But always check with your doctor before making any changes to your medication.
Generics versions of Leupo-22.5Mg Inj are typically more affordable because they don’t include the original brand's research, development, and marketing costs. They contain the same active ingredient and are approved for safety and effectiveness.
Most people don’t notice any difference. However, some may react to different fillers or coatings. If you notice any unusual symptoms after switching, consult your doctor.
Make sure the new medicine has the same active salt, strength, dosage form. Always confirm the change with your doctor or pharmacist.
Substitutes of Leupo-22.5Mg Inj meet the same safety and efficacy standards as Leupo-22.5Mg Inj, but small differences in absorption or formulation can exist. A doctor can help you choose the right one for your needs.
Yes. Substitutes of Leupo-22.5Mg Inj may vary in color, size, or shape due to differences in manufacturing and branding, but this does not affect how they work.
Yes, it’s generally safe to switch between multiple substitutes of Leupo-22.5Mg Inj if they have the same salt and strength. However, always inform your doctor so they can monitor how your body responds.
Yes, many people safely use substitutes of Leupo-22.5Mg Inj for long-term treatment. Just ensure it’s done under medical supervision.
If your symptoms stay under control or lab results remain stable, the substitute for Leupo-22.5Mg Inj is likely working well. Regular follow-ups with your doctor are important.
Absolutely. Even with the same salt, small differences can affect how your body responds when switching from Leupo-22.5Mg Inj to its substitute. Always consult your doctor before switching.
Leupo-22.5Mg Inj contains Leuprorelin, a synthetic hormone that works similar to the natural hormone, gonadotropin-releasing hormone (GnRH) by acting on the pituitary gland and decreases the levels of testosterone in men and oestrogen in women. Thereby, Leupo-22.5Mg Inj is used in the treatment of prostate cancer by inhibiting the growth of tumour or causing it to shrink.
Leupo-22.5Mg Inj may stop menstrual periods. However, after 7 to 12 weeks of taking the final dose of injection, periods will resume. Please consult a doctor if you have any concerns regarding this.
Leupo-22.5Mg Inj should be used with caution in diabetic patients as it may increase the risk of high blood sugar levels. Therefore, it is advised to regularly monitor blood sugar levels while taking Leupo-22.5Mg Inj and inform your doctor if you have diabetes before taking Leupo-22.5Mg Inj.
Leupo-22.5Mg Inj may be used to treat endometriosis (tissue lining the uterus known as endometrium grows outside the uterus). Leupo-22.5Mg Inj reduces oestrogen levels and causes menopause temporarily. Thereby, shrink the tissue outside the uterus or stop its growth.
Leupo-22.5Mg Inj may decrease bone density, especially when used for the treatment of premature puberty in children. Therefore, regular monitoring of bone density is recommended while taking Leupo-22.5Mg Inj.
Leupo-22.5Mg Inj should be used with extreme caution in patients suffering from depression as it may worsen the condition. Therefore, inform your doctor if you have any history of depression before taking Leupo-22.5Mg Inj.
No, Leupo-22.5Mg Inj is not a chemotherapy medicine. It is a synthetic hormone which belongs to the class of medicines called gonadotropin-releasing hormone (GnRH) agonists.
Yes, Leupo-22.5Mg Inj is a hormonal medicine that works by altering reproductive hormones. It is not recommended for use during pregnancy as it can harm the fetus and may lead to abortion. If you are pregnant or planning to become pregnant, please inform your doctor.
The common side effects of Leupo-22.5Mg Inj are pain, redness, swelling, or skin hardening at the injection site, muscle weakness, bone pain, inability to have an erection, breast tenderness, headache, vaginal dryness, changes in breast size, acne, or mood swings. If any of these side effects persist or worsen, please consult your doctor.
Leupo-22.5Mg Inj belongs to the class of synthetic hormones used in the treatment of prostate cancer in men, endometriosis, and hormone-responsive breast cancer in women. Also, it is used to treat premature puberty in children.
Intas Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Celon Laboratories Pvt Ltd
Natco Pharma Ltd
Admac Lifesciences(Oncology)
Cipla Ltd
BDR Pharmaceuticals Internationals Pvt Ltd
Sun Pharmaceutical Industries Ltd
Halsted Pharma Pvt Ltd
Adley Formulations
Neon Laboratories Ltd
Samarth Life Sciences Pvt Ltd
Glenmark Pharmaceuticals Ltd
United Biotech Pvt Ltd
Alkem Laboratories Ltd
Zydus Cadila
Zydus Healthcare Ltd
Emcure Pharmaceuticals Ltd
GLS Pharma Ltd
Allieva Pharma Pvt Ltd
Axiommax Oncology Pvt Ltd
Hetero Healthcare Pvt Ltd
Hetero Drugs Ltd
Mylan Pharmaceuticals Pvt Ltd
Fresenius Kabi India Pvt Ltd
Therdose Pharma Pvt Ltd
Khandelwal Laboratories Pvt Ltd
Pfizer Ltd
Torrent Pharmaceuticals Ltd
Zee Laboratories Ltd
Msn Laboratories Pvt Ltd
Medion Biotech Pvt Ltd
Cadila Healthcare Ltd
Getwell Life Sciences India Pvt Ltd
RPG Life Sciences Ltd
Lupin Ltd
Novartis India Ltd
Aureate Healthcare
Shilpa Medicare Ltd
Abbott India Ltd
Biochem Pharmaceutical Industries Ltd
Wembrace Biopharma Pvt Ltd
Adley Pharmaceuticals Ltd
Cadila Pharmaceuticals Ltd
Delarc Pharmaceuticals Pvt Ltd
Biomak Laboratories Pvt Ltd
Lucien Life Sciences
Amps Biotech Biotech Pvt Ltd
Reliance Formulation Pvt Ltd
Aimcad Biotech Pvt Ltd
Getwell Oncology Pvt Ltd
Astra Zeneca Pharma India Ltd
MEDICAMEN BIOTECH LTD
Reliance Life Sciences Pvt Ltd
Del Trade International Pvt Ltd
Getwell Pharmaceutical Pvt Ltd
Panacea Biotec Ltd
Bhardwaj India Pvt Ltd
Caitlin Oncology
Medaegis Biotek Pvt Ltd
Medicamen Biotech Ltd
PHARMACO INDUSTRIES PVT LTD
Dabur India Ltd
Oncostar Pharma Pvt Ltd
Sarabhai Chemicals (India) Pvt Ltd
Adley Oncology
Amneal Healthcare Pvt Ltd
Zuvius Lifesciences Pvt Ltd
ANAKAAS LIFE BIO SCIENCE PVT LTD.
Bangalore Pharmaceutical and Research Laboratory Pvt Ltd (BPRL)
Cytogen
Eli Lilly and Company (India) Pvt Ltd
Ipca Laboratories Ltd
Symbion Lifescience
Vhb Life Sciences Inc
Bruck Pharma Pvt Ltd
Eris Life Sciences Ltd
Hilfen Pharmaceuticals Pvt Ltd
Miracalus Pharma Pvt Ltd
Zuventus Healthcare Ltd
Admac Pharma Ltd
Anakaas Life Bio Science Pvt Ltd
Johnson & Johnson Pvt Ltd
KLIN LABORATORIES PVT. LTD.
Maximal Healthcare Pvt Ltd
Oncobiotek Drugs Pvt Ltd
Roche Diagnostics India Pvt Ltd
Sayre Therapeutics Pvt Ltd
Adley & Bdl
Akumentis Healthcare Ltd
Aprazer Healthcare Pvt Ltd
Biocon Ltd
Caitlin Biotech Pvt Ltd
Ferring Pharmaceuticals Pvt Ltd
Fresenius Kabi Oncology Ltd
GlaxoSmithKline Pharmaceuticals Ltd
Hetero Healthcare Ltd
Mankind Pharma Pvt Ltd
Merck Ltd
Prevego Healthcare & Research Pvt Ltd